Former Pfenex Exec Chen Joins Metacrine as Chief Medical Officer

15:02 EDT 14 Sep 2018 | Xconomy

Hubert Chen has been appointed chief medical officer of San Diego biotech Metacrine. Chen most recently worked as chief medical officer of Pfenex (NYSE American: PFNX). Metacrine develops drugs for liver and gastrointestinal diseases. Last year, Metacrine raised $22 million in Series B financing. The company plans to test its lead drug, MET409, as a […]

Original Article: Former Pfenex Exec Chen Joins Metacrine as Chief Medical Officer


More From BioPortfolio on "Former Pfenex Exec Chen Joins Metacrine as Chief Medical Officer"

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...